A citation-based method for searching scientific literature

Romain Guièze, Mélanie Pages, Lauren Véronèse, Patricia Combes, Richard Lemal, Mathilde Gay-Bellile, Martine Chauvet, Mary Callanan, Fabrice Kwiatkowski, Bruno Pereira, Philippe Vago, Jacques-Olivier Bay, Olivier Tournilhac, Andreï Tchirkov. Oncotarget 2016
Times Cited: 11







List of co-cited articles
113 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions.
Kathrin Thomay, Caroline Fedder, Winfried Hofmann, Hans Kreipe, Michael Stadler, Jan Titgemeyer, Ingo Zander, Brigitte Schlegelberger, Gudrun Göhring. Ann Hematol 2017
9
44



Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner, S Stilgenbauer, A Benner, E Leupolt, A Kröber, L Bullinger, K Döhner, M Bentz, P Lichter. N Engl J Med 2000
27

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Michael Hallek, Bruce D Cheson, Daniel Catovsky, Federico Caligaris-Cappio, Guillaume Dighiero, Hartmut Döhner, Peter Hillmen, Michael J Keating, Emili Montserrat, Kanti R Rai,[...]. Blood 2008
27

Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.
Carmen Diana Herling, Marion Klaumünzer, Cristiano Krings Rocha, Janine Altmüller, Holger Thiele, Jasmin Bahlo, Sandra Kluth, Giuliano Crispatzu, Marco Herling, Joanna Schiller,[...]. Blood 2016
74
27

Mutations driving CLL and their evolution in progression and relapse.
Dan A Landau, Eugen Tausch, Amaro N Taylor-Weiner, Chip Stewart, Johannes G Reiter, Jasmin Bahlo, Sandra Kluth, Ivana Bozic, Mike Lawrence, Sebastian Böttcher,[...]. Nature 2015
532
27

POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
Andrew J Ramsay, Víctor Quesada, Miguel Foronda, Laura Conde, Alejandra Martínez-Trillos, Neus Villamor, David Rodríguez, Agnieszka Kwarciak, Cecilia Garabaya, Mercedes Gallardo,[...]. Nat Genet 2013
179
27

Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.
Patricia Dos Santos, Julieta Panero, Virginia Palau Nagore, Carmen Stanganelli, Raimundo F Bezares, Irma Slavutsky. Tumour Biol 2015
13
27

Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.
T J Hamblin, Z Davis, A Gardiner, D G Oscier, F K Stevenson. Blood 1999
27

Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease.
Thet Thet Lin, Kevin Norris, Nicole H Heppel, Guy Pratt, James M Allan, David J Allsup, James Bailey, Lynn Cawkwell, Robert Hills, Julia W Grimstead,[...]. Br J Haematol 2014
63
27


Telomeric damage in early stage of chronic lymphocytic leukemia correlates with shelterin dysregulation.
Adeline Augereau, Claire T'kint de Roodenbeke, Thomas Simonet, Serge Bauwens, Béatrice Horard, Mary Callanan, Dominique Leroux, Laurent Jallades, Gilles Salles, Eric Gilson,[...]. Blood 2011
38
27

Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Haeryoung Kim, Jeong Eun Yoo, Jai Young Cho, Bong-Kyeong Oh, Yoo-Seok Yoon, Ho-Seong Han, Hye Seung Lee, Ja June Jang, Sook Hyang Jeong, Jin Wook Kim,[...]. J Hepatol 2013
41
27

Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication.
Agnel Sfeir, Settapong T Kosiyatrakul, Dirk Hockemeyer, Sheila L MacRae, Jan Karlseder, Carl L Schildkraut, Titia de Lange. Cell 2009
636
27

TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres.
Jeffrey Zheng-Sheng Ye, Jill R Donigian, Megan van Overbeek, Diego Loayza, Yan Luo, Andrew N Krutchinsky, Brian T Chait, Titia de Lange. J Biol Chem 2004
219
27

Telomerase modulates Wnt signalling by association with target gene chromatin.
Jae-Il Park, Andrew S Venteicher, Ji Yeon Hong, Jinkuk Choi, Sohee Jun, Marina Shkreli, Woody Chang, Zhaojing Meng, Peggie Cheung, Hong Ji,[...]. Nature 2009
432
27

p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2.
J Karlseder, D Broccoli, Y Dai, S Hardy, T de Lange. Science 1999
837
27

How shelterin protects mammalian telomeres.
Wilhelm Palm, Titia de Lange. Annu Rev Genet 2008
27

Control of human telomere length by TRF1 and TRF2.
A Smogorzewska, B van Steensel, A Bianchi, S Oelmann, M R Schaefer, G Schnapp, T de Lange. Mol Cell Biol 2000
564
27

TRF2 protects human telomeres from end-to-end fusions.
B van Steensel, A Smogorzewska, T de Lange. Cell 1998
27

Mammalian telomeres end in a large duplex loop.
J D Griffith, L Comeau, S Rosenfield, R M Stansel, A Bianchi, H Moss, T de Lange. Cell 1999
27

Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.
Delphine Poncet, Aurélie Belleville, Claire t'kint de Roodenbeke, Aude Roborel de Climens, Elsa Ben Simon, Hélène Merle-Beral, Evelyne Callet-Bauchu, Gilles Salles, Laure Sabatier, Jozo Delic,[...]. Blood 2008
92
27

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
201
27

ALTernative Telomere Maintenance and Cancer.
Robert L Dilley, Roger A Greenberg. Trends Cancer 2015
107
27

Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia.
Billy Michael Chelliah Jebaraj, Eugen Tausch, Dan A Landau, Jasmin Bahlo, Sandra Robrecht, Amaro N Taylor-Weiner, Johannes Bloehdorn, Annika Scheffold, Daniel Mertens, Sebastian Böttcher,[...]. Leukemia 2019
8
37

Short telomere length is associated with NOTCH1/SF3B1/TP53 aberrations and poor outcome in newly diagnosed chronic lymphocytic leukemia patients.
Larry Mansouri, Pawel Grabowski, Sofie Degerman, Ulrika Svenson, Rebeqa Gunnarsson, Nicola Cahill, Karin Ekström Smedby, Christian Geisler, Gunnar Juliusson, Göran Roos,[...]. Am J Hematol 2013
32
18

Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.
Göran Roos, Alexander Kröber, Pawel Grabowski, Dirk Kienle, Andreas Bühler, Hartmut Döhner, Richard Rosenquist, Stephan Stilgenbauer. Blood 2008
97
18

Telomeres in cancer: tumour suppression and genome instability.
John Maciejowski, Titia de Lange. Nat Rev Mol Cell Biol 2017
254
18

Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations.
Rajendra N Damle, Franak M Batliwalla, Fabio Ghiotto, Angelo Valetto, Emilia Albesiano, Cristina Sison, Steven L Allen, Jonathan Kolitz, Vincent P Vinciguerra, Prasad Kudalkar,[...]. Blood 2004
130
18

Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.
Enrica Rampazzo, Laura Bonaldi, Livio Trentin, Carlo Visco, Sonia Keppel, Silvia Giunco, Federica Frezzato, Monica Facco, Elisabetta Novella, Ilaria Giaretta,[...]. Haematologica 2012
39
18

Telomere dysfunction and tumour suppression: the senescence connection.
Yibin Deng, Suzanne S Chan, Sandy Chang. Nat Rev Cancer 2008
268
18

Telomeres shorten during ageing of human fibroblasts.
C B Harley, A B Futcher, C W Greider. Nature 1990
18

Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.
Pawel Grabowski, Magnus Hultdin, Karin Karlsson, Gerard Tobin, Anna Aleskog, Ulf Thunberg, Anna Laurell, Christer Sundström, Richard Rosenquist, Göran Roos. Blood 2005
100
18


Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.
Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, Thorsten Zenz, Marianna Rossi, Konstanze Döhner, Andreas Bühler, Sebastian Böttcher, Matthias Ritgen, Michael Kneba,[...]. Blood 2014
309
18

Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.
R N Damle, T Wasil, F Fais, F Ghiotto, A Valetto, S L Allen, A Buchbinder, D Budman, K Dittmar, J Kolitz,[...]. Blood 1999
18

Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
J C Strefford, L Kadalayil, J Forster, M J J Rose-Zerilli, A Parker, T T Lin, N Heppel, K Norris, A Gardiner, Z Davies,[...]. Leukemia 2015
34
18

Telomere measurement by quantitative PCR.
Richard M Cawthon. Nucleic Acids Res 2002
18

A quantitative real-time PCR method for absolute telomere length.
Nathan O'Callaghan, Varinderpal Dhillon, Philip Thomas, Michael Fenech. Biotechniques 2008
142
18


TIN2, a new regulator of telomere length in human cells.
S H Kim, P Kaminker, J Campisi. Nat Genet 1999
385
18


Telomere dysfunction and cell survival: roles for distinct TIN2-containing complexes.
Sahn-Ho Kim, Albert R Davalos, Seok-Jin Heo, Francis Rodier, Ying Zou, Christian Beausejour, Patrick Kaminker, Steven M Yannone, Judith Campisi. J Cell Biol 2008
39
18

Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
Mikako Yamada, Naoki Tsuji, Masashi Nakamura, Ryosuke Moriai, Daisuke Kobayashi, Atsuhito Yagihashi, Naoki Watanabe. Anticancer Res 2002
54
18

TIN2-tethered TPP1 recruits human telomerase to telomeres in vivo.
Eladio Abreu, Elena Aritonovska, Patrick Reichenbach, Gaël Cristofari, Brad Culp, Rebecca M Terns, Joachim Lingner, Michael P Terns. Mol Cell Biol 2010
164
18


Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer.
K Miyachi, M Fujita, N Tanaka, K Sasaki, M Sunagawa. J Exp Clin Cancer Res 2002
38
18

Telomeres: protecting chromosomes against genome instability.
Roderick J O'Sullivan, Jan Karlseder. Nat Rev Mol Cell Biol 2010
545
18

Telomere protection by TPP1/POT1 requires tethering to TIN2.
Kaori K Takai, Tatsuya Kibe, Jill R Donigian, David Frescas, Titia de Lange. Mol Cell 2011
137
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.